Leaderboard Ad

Get Inspired at the Honorary Guest Lectures

Lectures1Helping to convey the meeting theme of “Transforming. Thriving. Together.,” the following array of accomplished individuals embody the characteristics and accomplishments that power our strength and will to surpass limitations. As leaders and colleagues, they have positively affected our lives and our patients’ lives. They make us proud of what they have accomplished in their fields and offer a foundation for continued progress.

John Conley, MD Lecture on Medical Ethics

8:30 am Sunday, September 21 (Opening Ceremony Keynote Speaker)

“The Pursuit of Quality and Value: Why it Matters”

Rosemary Gibson is senior advisor to The Hastings Center and an editor for JAMA Internal Medicine and author. At the Robert Wood Johnson Foundation in Princeton, NJ, she led national healthcare quality and safety initiatives for 16 years. As chief architect of the foundation’s long-term strategy, she has developed the practice of palliative care in more than 1,600 U.S. hospitals and for this received the Lifetime Achievement Award from the American Academy of Hospice and Palliative Medicine. Her publications often interpret the costs to individuals, and more broadly to society, of the U.S. healthcare’s shortcomings, and have received acclaim by peers and medical press.

AAO-HNS/F International Hearing Foundation/Michael M. Paparella, MD Endowed Lecture for Distinguished Contributions in Clinical Otology

9:30 am Monday, September 22

“Cholesteatoma—What We Have Learned in 3,000 Years”


Richard A. Chole, MD, PhD, is a highly skilled clinician and surgeon, and an outstanding administrator. After earning an MD from the University of Southern California, Dr. Chole completed a residency and fellowship at the University of Minnesota School Of Medicine. In tandem with this effort, he also finished a PhD in Otolaryngology Anatomy-Biochemistry track from the graduate school. Dr. Chole chose a position with the department of otolaryngology at University of California-Davis and later became a professor and chairman of its otolaryngology department. He is an outstanding teacher and advisor and is active as a research sponsor. His invitation to serve on the Advisory Council of the National Deafness and Other Communication Disorders (NIDCD) of the National Institutes of Health by the Secretary of Health and Human Services is an outstanding honor.

Eugene N. Myers, MD International Lecture on Head and Neck Cancer

9:30 am Tuesday, September 23

“Treatment of Nasopharynegeal Cancer: State of the Art”

Sheng-Po Hao, MD, FICS, is professor and chairman of the department of otolaryngology of Shin Kong Wu Ho-Su Memorial Hospital and Fu Jen Catholic University in Taiwan. After his residency at Chang Gung Memorial Hospital, he pursued an International Fellowship in Head and Neck Surgery in Pittsburgh with Dr. Myers. He has published hundreds of articles and book chapters. Dr. Hao has given numerous international lectures including the Keynote Lecture in IFOS Seoul 2013. Dr. Hao is the founding president of the Taiwan Head and Neck Society, Taiwan Oral Cancer Prevention and Therapy Association and the past president of Taiwan Skull Base Society. He is also the founding president and currently the secretary general of the Asian Society of Head and Neck Oncology.

H. Bryan Neel III MD, PhD, Distinguished Research Lecture

9:30 am Wednesday, September 24

“Genomics in Personalized Medicine and Surgery for Head and Neck Cancer”

Carter Van Waes, MD, PhD, is clinical director and chief, Head and Neck Surgery branch, NIDCD, and senior investigator, Radiation Oncology Sciences Program, NCI. In 1987, he received an NIH Medical Scientist Training Program Award and earned his MD and PhD in Tumor Immunology from the University of Chicago. He completed his otolaryngology-head and neck surgery residency at the University of Michigan, where he also completed an NIH-supported postdoctoral fellowship in cancer. He established an NIDCD and inter-institute program with NCI and NIDCR in Head and Neck Cancer. Recently, Dr. Van Waes has contributed to the broad understanding of the genetic alterations that contribute to HNSCC development, as part of The Cancer Genome Atlas NIH initiative.